Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|May 18, 2016
COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational statusHana Plesingerova, Zuzana Librova, Karla Plevova, et al.
Molecular Oncology|May 21, 2024
Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencingTerezia Kurucova, Kamila Reblova, Pavlina Janovska, et al.
Epigenetics|April 8, 2016
Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expressionPradeep Kumar Kopparapu, Sujata Bhoi, Larry Mansouri, et al.
British Journal of Haematology|October 7, 2019
High-throughput sequencing of T-cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignanciesAlexander Komkov, Anna Miroshnichenkova, Gaiaz Nugmanov, et al.
Carcinogenesis|December 6, 2013
Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemiaJana Kminkova, Marek Mraz, Kristina Zaprazna, et al.
The Journal of Molecular Diagnostics : JMD|June 3, 2021
LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid MalignanciesVeronika Navrkalova, Karla Plevova, Jakub Hynst, et al.
Blood Advances|July 12, 2021
RPS15 mutations rewire RNA translation in chronic lymphocytic leukemiaStavroula Ntoufa, Marina Gerousi, Stamatia Laidou, et al.
Haematologica|June 11, 2026
Multicolor detection of chronic myeloid leukemia stem cells, including novel marker CD69, predicts survival and early hematological toxicityMartin Culen, Marianna Romzova, Dagmar Smitalova, et al.
International Journal of Molecular Sciences|February 15, 2022
The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic LeukemiaShamil Urazbakhtin, Anastasia Smirnova, Anastasiya Volakhava, et al.
BMC Cancer|February 4, 2022
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changesHelena Olbertova, Karla Plevova, Sarka Pavlova, et al.
Pageof 6